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Abstract
In humans, the cobalamin (Cbl) -binding protein transcobalamin (TC) transports Cbl from the intestine and into all the cells
of the body, whereas the glycoprotein haptocorrin (HC), which is present in both blood and exocrine secretions, is able to
bind also corrinoids other than Cbl. The aim of this study is to explore the expression of the Cbl-binding protein HC as well
as TC in mice. BLAST analysis showed no homologous gene coding for HC in mice. Submaxillary glands and serum displayed
one protein capable of binding Cbl. This Cbl-binding protein was purified from 300 submaxillary glands by affinity
chromatography. Subsequent sequencing identified the protein as TC. Further characterization in terms of glycosylation
status and binding specificity to the Cbl-analogue cobinamide revealed that mouse TC does not bind Concanavalin A
sepharose (like human TC), but is capable of binding cobinamide (like human HC). Antibodies raised against mouse TC
identified the protein in secretory cells of the submaxillary gland and in the ducts of the mammary gland, i.e. at locations
where HC is also found in humans. Analysis of the TC-mRNA level showed a high TC transcript level in these glands and also
in the kidney. By precipitation to insolubilised antibodies against mouse TC, we also showed that .97% of the Cbl-binding
capacity and .98% of the Cbl were precipitated in serum. This indicates that TC is the only Cbl-binding protein in the
mouse circulation. Our data show that TC but not HC is present in the mouse. Mouse TC is observed in tissues where
humans express TC and/or HC. Mouse TC has features in common with both human TC and HC. Our results suggest that the
Cbl-binding proteins present in the circulation and exocrine glands may vary amongst species.
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Introduction
In humans, two circulating cobalamin (Cbl) -binding proteins
have been identified and characterized: transcobalamin (TC) and
haptocorrin (HC). TC transports Cbl into all cells of the body via
binding to CD320, a recently identified membrane receptor [1].
The function of HC remains unknown, but the protein carries the
major part of circulating Cbl and it is present in secretions such as
saliva and milk [2]. A characteristic feature of HC is that it has a
higher affinity for a wider spectrum of Cbl forms than TC.
Moreover, recent studies have shown that so-called Cbl-analogues
capable of binding to HC are present in the human circulation [3].
TC and its encoding gene, TCN2, have been observed in all
animals including mouse, rat, monkey, hog, horse, opossum, cow,
dog, chicken, and chimpanzee [4]. HC and/or its encoding gene,
TCN1, have been found in hog, cow, dog, rhesus monkey, horse,
chimpanzee, platypus [5], and rabbit [6]. In hen, the Cbl-binding
protein has been purified and partly characterized [7], but with no
definitive conclusion as to its classification as TC or HC. In rat [8]
and opossum [9], the presence of HC has been suggested by
indirect methods, but without protein purification and final
classification.
Since mice are commonly used experimental animals and
s e r v ea sp h y s i o l o g i c a lm o d e l s ,w ew a n t e dt oe x p l o r et h e
expression of the Cbl-binding protein HC as well as TC
in mice.
Materials and Methods
DNA/BLAST analysis
DNA/BLAST sequence search and analysis was performed
using the National Center for Biotechnology Information (NCBI)
website [10]. The nucleotide sequences for human TCN1 were
compared with the mouse sequences by use of the Basic Local
Alignment Search Tool (BLAST). The human TCN1 genomic
sequence was compared to the mouse genome by use of the Map
Viewer function. Likewise, the sequence of TCN2 was searched.
Experimental animals and tissues
A wide variety of different inbred mouse strains were obtained
from the animal section, Institute of Medical Microbiology and
Immunology, Aarhus University, Denmark and from the Institute
of Biomedical Sciences, Panum Institute, University of Copenha-
gen, Denmark. All mice were in care of the animal section
enjoying standard living conditions for laboratory mice. They were
part of no experimental studies while alive and were destined to be
killed independently of the present study. On the day the mice
were sacrificed, each mouse was taken directly from the cage and
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instantly placed on dry ice or in liquid nitrogen and subsequently
stored in aliquots at – 80 uC. All mammary glands were taken
from lactating mice. Blood was either drawn from the orbital sinus
(serum) or from the vena cava using a heparin-coated syringe
(plasma); in both settings prior anesthesia of the mice was applied.
Pre-treatment of tissues and blood for protein analysis
Keeping the sample on ice, 10 mL homogenisation buffer
(10 mM PIPES pH 7.4 (Sigma, Brøndby, Denmark), 1 mM
EGTA (Sigma, Brøndby, Denmark), 3 mM MgCl2,6 H 2O (Merck,
Damstadt, Germany), 400 mM NaCl, 2 tablets per 25 mL buffer
of proteinase inhibitor cocktail (Cat. No. 11697498001, Roche
Diagnostics, Mannheim, Germany)) were added per mg tissue.
The tissue was homogenized using a tissue ruptor (Qiagen,
Copenhagen, Denmark) and sonicated (MSE probe universal) 3
times 10 s. The sample was centrifuged for 40 min at 20000 G at
4u. The supernatant was kept at – 20 uC until analyzed. Mouse
blood was stored at 220u until analyzed.
For comparative analysis, human TC was obtained from partly
purified spermal plasma [11] and human HC was obtained either
from a pool of saliva originally collected in relation to a study of
the salivary content of HC [12] or from a patient with a high
plasma concentration of HC [13].
Unsaturated cobalamin-binding capacity and total
cobalamin
Unsaturated Cbl-binding capacity (UB12BC) was measured by
adding radiolabeled Cbl (Cbl*) ([
57Co]cyanocobalamin, Kem-En-
Tec, Taastrup, Denmark) with a known specific activity. Unbound
Cbl was removed by addition of coated charcoal while employing
a previously described method [14].
Samples with a Cbl-binding capacity above 0.9 nM were
diluted five (mammary glands) or 100–1000 (parotid and
submaxillary glands) times in 0.1% PBS (0.1 M phosphate buffer
pH 8.0 (Ampliqon, Skovlunde, Denmark), 1 g/L bovine serum
albumin (analyzed for Cbl content, Sigma)) prior to analysis.
The total Cbl concentration was measured using Cobas 6000 E
immunoassay system (Roche Diagnostics, Hvidovre, Denmark)
with a detection range of 55–1476 pM. Samples were diluted with
diluents supplied by the manufacturer prior to analysis.
Characterization of the unsaturated Cbl-binding protein
The protein’s binding affinities for Cbl and cobinamide (Cbi)
were explored in crude protein extracts of mouse submaxillary
glands, and for human TC and HC. The analysis was performed
in a competitive assay as described previously [15].
The glycosylation status of the Cbl-binding protein from
extracts of mouse submaxillary glands was explored by precipi-
tation by Concanavalin A sepharose (Con A Sepharose 4B,
Amersham Biosciences, Uppsala, Sweden), a lectin known to bind
a-D-mannopyranosyl, a -D-glucopyranosyl, and sterically related
residues. For each sample (mouse submaxillary gland extract,
human TC, and human plasma HC), the UB12BC was adjusted to
2 nM by dilution with binding buffer (20 mM Tris-HCl pH 7.4,
0.5 M NaCl) and 600 mL of each sample was incubated with
10 mL 5 nM Cbl*, approx. 6500 cpm, for 30 min at room
temperature (RT). 100 mL Con A sepharose (prepared according
to the manufacturer’s instructions) and 200 mL binding buffer
were added and the sample was incubated 1 h at RT before
centrifugation for 5 min at 8.0 G. The Cbl* present in the
supernatant and the precipitate was measured by gamma counting
(1470 Wizard, Wallac Automatic Gamma Counter).
Purification and sequencing of mouse submaxillary Cbl-
binding protein
The unsaturated Cbl-binding protein present in 300 ml crude
protein extract from more than 300 mouse submaxillary glands
was purified to homogeneity by affinity chromatography where
sepharose-coupled hydroxyl-Cbl was used, essentially as previously
described [16].
8 mL sepharose slurry (EAH sepharose 4B GE Healthcare,
Uppsala, Sweden) was washed with 200 mL 0.1 M NaH2PO4
pH 7.5. Thereafter, 10 mL of 1 mg/mL hydroxy-Cbl (GEA,
Copenhagen, Denmark) mixed with 3 mL 0.1 M NaH2PO4
pH 7.5 was applied to the sepharose, gently mixed, and incubated
for 5 hours at 57u while gently mixing the solutionevery 20-30 min.
30 mL 20%sodiumazide wasadded per 15 mL B12-sepharose, and
the sepharose was placed at 4 uC. Prior to use, the B12-sepharose
was washed with 50 volumes of 0.1 M NaH2PO4 pH 7.5 followed
by 30 volumes demineralised water and six volumes of 0.1 M
NaH2PO4 pH 7.5. The mouse submaxillary extract was applied to
the column with a flow rate adjusted to allow the extract to incubate
with the B12-sepharose for $5 min. The column was washed with
approx. 15 volumes of 0.1 M Tris pH 7.5 with 1 M NaCl and with
approx. three volumes of 0.1 M NaH2PO4 pH 7.5. Absorbed Cbl-
binding protein was eluted by incubating the column at 37 uC over
night and by applying approx. two volumes of 0.1 M NaH2PO4
pH 7.5 preheated to 37 uC. The elution procedure was repeated
and the pooled eluate was dialyzed employing 14 kDa cut-off
dialysis tubes (Medicell International, London, U.K.) against 0.1 M
NaH2PO4 pH 7.5 for 6 hours at 4 uC and against demineralised
water at 4 uC over night, lyophilised (HETOVAC), and kept at
220 uC until further use.
Protein purity was evaluated by Coomassie-stained 12% SDS-
PAGE by running 20 mL 275 mg/L protein on precast 12% Tris-
HCl gel (Bio Rad, Hercules, California, USA).
Two major bands from an SDS-gel were cut out of the gel and
after reduction with dithioerythritol following incubation with
iodoacetamide, the samples were digested with trypsin, and
extracted peptides were analyzed on a Voyager-DE MALDI-
TOF mass spectrometer (Applied Biosystems, CA, USA). The data
were searched using the Mascot search engine [17].
Identification and alignment of protein sequences
Protein sequences of human HC (NP_001053), human TC
(NP_000346), human IF (NP_005133), mouse TC (NP_056564),
and rat TC (NP_071979) were found in the protein database of the
NCBI website [18] using search term ‘‘TCN’’ and the respective
organisms. Protein sequence alignment was done using clustalW2
at the homepage of the European Molecular Biology Laboratory-
European Bioinformatics Institute (EMBL EBI) using default
settings [19], [20].
Antibodies against mouse TC: production, test, and use
Polyclonal antibodies (anti-mouse TC) were produced by
immunizing a rabbit six times with approx. 7 mg purified protein
mixed with Freund’s incomplete adjuvant (Sigma, Brøndby,
Denmark) to a volume of 600 mL. Immunizations were given sub-
cutaneously at weeks 1, 3, 5, 7, 11, and 15. After 19 weeks, the
rabbit was bled to death and serum was collected and stored in
aliquots at 220u until the gamma globulin fraction was purified as
described previously [21]. The purified, lysophilised anti-mouse
TC was stored at 280 uC.
To test the binding specificity of anti-mouse TC, it was used in
standard Western blot of 10% native PAGE (MiniProtean H TGX
TM, BioRad, Hercules, CA, USA) analysis of serum, crude extract
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antibody was polyclonal goat anti-rabbit immunoglobulins/HRP
(DAKO, Glostrup, Denmark) and the results were visualised using
UVP BiospectrumAC Imaging System (AH diagnostics).
Anti-mouse TC was used in a precipitation study: 1 mg purified
gamma globulin of rabbit anti-mouse TC was coupled to
proteinA/G+agarose according to the manufacturer’s instructions
(SantaCruz Biotech, California, USA). The binding capacity was
calculated based on experiments where increasing amounts of
anti-mouse TC-agarose were added to a constant submaxillary
gland crude protein extract (UB12BC 25 nM) and by measuring
the UB12BC before and after 1 h of incubation at RT while
rolling. To evaluate the presence of other Cbl-binding proteins in
mouse serum, the sum of UB12BC and Cbl was calculated and a
2-fold excess binding capacity of anti-mouse TC-agarose was
added to the sample. UB12BC and Cbl were measured before and
after absorption as described above and the fraction of precipitated
UB12BC and Cbl was calculated.
For immunohistochemistry, submandibular glands and lactating
mammary glands were taken from five mice and fixed in ice-cold
4% paraformaldehyde in 0.1 M phosphate buffer pH 7.4. The
tissue samples were embedded in paraffin and cut into 10-mm
sections using a microtome. The sections were incubated for 5 min
in 2% bovine serum albumin followed by 18 h at 4uC with the
primary antiserum diluted 1:3200. For visualisation of the
immunoreactions, the sections were incubated for 1 h with
biotinylated porcine anti-rabbit immunoglobulins (code no. E 353,
DakoCytomation), diluted 1:40 as the second layer, followed by
StreptABComplex/horseradish peroxidase (code no. E 353,
DakoCytomation) diluted 1:200 as the third layer, and, finally,
stained by means of 3,3-diaminobenzidine for 30 min. The
sections were counterstained with hematoxylin. As a control for
non-specific staining, the primary antiserum was replaced by pre-
immune serum from the same rabbit in the same dilutions.
mRNA expression of TC in mouse tissues
Total RNA was purified from mouse tissues by the use of
QIAamp RNA purification kit (Qiagen, Hilden, Germany)
according to the manufacturer’s instructions. The concentration
of RNA in each purified sample was measured by optical density
at wavelength 260 nm and adjusted to 0.1 mg/mL in RNAse free
H2O. 1 mL (0.1 mg) RNA was mixed with 5 mL 25 mM MgCl
(Perkin Elmer, Foster City, USA), 8 mL 10 mM dNTP mix (dATP,
dTTP, dGTP, dCTP, Pharmacia Biotech/GE Healthcare,
Hillerød, Denmark), 1 mL5 0 mM 16mer d(T) oligonucleotide
primers (DNA Technology, Risskov, Denmark), 2 mL 10 x PCR-
buffer (Applied Biosystems, CA, USA), 1 mL5 0U / mL reverse
transcriptase (Applied Biosystems, CA, USA), and 1 mL2 0U / mL
RNase inhibitor (Applied Biosystems, CA, USA) reaching a total
volume of 20 mL. The sample was incubated for 30 min at 42 uC
and stored at 220 uC.
Specific primers were used for mouse TC (forward (59-
CTTTGCTGGATCTTCCTTGG-39), starting at base 1256 in
the mouse TCN2 sequence, accession NM 15749 in the NCBI
Nucleotide Database; reverse (59-TCCTGGGGTTTGTAGT-
CAGC-39), starting at base 1456 in the mouse TCN2 sequence,
accession NM 15749 in the NCBI Nucleotide Database). 1 ml
cDNA synthesized as described above was mixed with 5 mL SYBR
Green (Light Cycler 480 SYBR Green 1 Master, Roche,
Indianapolis, USA), 0.5 mL 5 pmol/mL forward and reverse
primers, and RN’ase free H2O to a volume of 10 mL. The PCR
program was conducted as follows: Preincubation for 10 min at
95 uC followed by 50 cycles of: 10 s at 95 uC, 20 s at 60 uC, and
5 s at 72 uC. Serial dilutions of RNA from the mouse
cardiomyocyte cell line HL-1 were used as calibrators in the real
time PCR, and the lowest dilution was assigned a concentration of
TC-mRNA of 1.22?10
24 arbitrary units. The cell line was a
generous gift from Dr. William Claycomb, Dept. of Biochemistry
& Molecular Biology, School of Medicine, New Orleans, USA.
The PCR products were examined by 1.5% agarose gel
electrophoresis and the DNA fragments were shown to have the
expected size of 201 bases in accord with the primer design. The
DNA bands were purified as previously described [22] and
sequenced by Eurofins, MWG Operon to verify the correct
identity of the amplified cDNA.
Data analyses
GraphPad Prism 4 software (GraphPad Software Inc., Califor-
nia, USA) was used for data analyses.
Results
DNA/BLAST analysis
We found that BLAST analysis at protein and nucleotide level
in mice detected no protein or DNA sequence comparable to the
HC/TCN1 seen in man (data not shown). A gene coding for TC
(TCN2) has previously been identified in mice [23]. These results
sparked the present effort to identify the Cbl-binding proteins in
mouse blood and tissues.
Cobalamin-binding capacity and concentration of total
cobalamin
We performed a broad screening of the UB12BC and Cbl
content in tissues which in humans contain high levels of Cbl and/
or of the Cbl-binding proteins HC or TC.
Mouse lactating mammary glands, kidney, and liver had low
Cbl-binding capacities as compared to submaxillary and parotid
glands, Table 1. The highest Cbl concentration was observed in
the liver followed by the kidney, parotid, submaxillary, and
lactating mammary glands. Among all other tissues examined,
only the stomach (data not shown) and plasma showed Cbl-
binding capacities .1 pmol/g, whereas the esophagus, small
intestine, colon, spleen, pancreas, heart, trachea, lung, lymph
nodes, skin, muscle, and brain had Cbl-binding capacities
,1 pmol/g (data not shown).
Table 1. The unsaturated Cbl-binding capacity (UB12BC) and
cobalamin content (Cbl) in selected mouse tissues and
plasma.
UB12BC Cbl
Median (range) pmol/g Median (range) pmol/g
Parotid gl. (n=6) 400 (190–510) 190 (130–300)
Submaxillary gl. (N=7)140 (2–270) 170 (150–220)
Mammary gl. (n=6) 0.5 (0–3) 59 (40–85)
Liver (n=7) ,1 580 (490–670)
Kidney (n=7) ,1 460 (220–570)
Plasma (n=7) 24 (20–29) 29 (28–37)
Results are shown as pmol (median and range) content per g of wet tissue/ml
plasma. The number (n) of mice examined are indicated in brackets.
doi:10.1371/journal.pone.0020638.t001
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In mice, the tissues most likely to have a high content of HC
would be the exocrine glands, since human exocrine secretions
contain high HC levels. We therefore characterized the Cbl-
binding capacity of the mouse submaxillary glands.
We first compared the binding affinities towards Cbl and the
Cbl-analogue Cbi of mouse submaxillary Cbl-binding protein
(mouse Cbl-binder) with that of human HC and TC.
Mouse Cbl-binder, human HC, and human TC showed
comparable binding curves for binding of Cbl, Figure 1A,
supporting a comparable affinity towards Cbl for the three
proteins. In contrast the binding curves for Cbi showed marked
differences, Figure 1B. Kd for binding of Cbi to each of the
proteins were estimated as the concentration of Cbi able to
displace 50% of labeld Cbl from the binder. In accord with
previous work [15] Kd for human HC (,0.5 nmol/L) was low
compared to Kd for human TC ( 300 nmol/L). The mouse Cbl-
binder bound Cbi better than human TC, but not as efficiently as
human HC and showed a Kd of 2 nmol/L.
The glycosylation status of the mouse Cbl-binding protein was
examined by precipitation with Con-A. Mouse Cbl-binder and
human TC did not bind to the mannose-recognising lectin Con-A,
while a large fraction of human HC did bind to this lectin (data not
shown). Thus, the initial studies showed that the mouse Cbl-binder
has characteristics resembling those of HC (recognition of
corrinoids) and those of TC (lack of ability to bind to Con-A).
Purification and amino acid sequence alignment of the
mouse Cbl-binder
To further explore the nature of the mouse Cbl-binder, we
purified the Cbl-binder present in submaxillary glands. Mouse
submaxillary glands were chosen because of their relatively high
Figure 1. The binding affinities of mouse and human Cbl-binding proteins towards Cbl and Cbi. The binding affinities of the Cbl-binder
from mouse submaxillary glands (mouse), human TC, and human HC towards (A) Cbl and (B) Cbi (see Materials and Methods for details).
doi:10.1371/journal.pone.0020638.g001
Figure 2. Protein purity and Western blot analyses. (A) 12% reduced SDS-PAGE showing purity of the purified Cbl-binding protein from mouse
submaxillary glands. Lane 1) marker; Lane 2) purified mouse TC (see Materials and Methods for details). (B) Western blot employing anti-mouse
antibodies on proteins separated by 10% native PAGE. Lane 1) approx. 60 fmol purified mouse TC (approx. 40kDa); Lane 2) extract of the Cbl-binder
from mouse submaxillary glands corresponding to a total amount of Cbl+UB12BC of 64 fmol; Lane 3) mouse serum corresponding to a total amount
of Cbl+UB12BC of 72 fmol.
doi:10.1371/journal.pone.0020638.g002
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submaxillary glands are considerably larger (average 56 mg) than
the parotid glands (average 21 mg).
The Cbl-binding protein was purified to homogeneity from
an extract of 300 glands in a one-step procedure by affinity
chromatography employing Cbl coupled to sepharose. A total
of approx. 0.3 mg protein was purified with a purification
recovery of approx. 85%. As judged from reduced SDS-PAGE,
the purified protein had an approx. 40 kDa molecular
mass (Figure 2A), which is similar to the molecular mass of
human TC.
Sequencing of the purified protein proved that it was mouse TC
as the results from two bands covered the amino acid sequence of
mouse TC corresponding to 29 % and 20 % respectively, clearly
identifying both bands as TC (data not shown).
After identifying the purified mouse Cbl-binder as mouse TC in
the database, we aligned the protein sequence of mouse TC to that
of the human binders (Supporting Figure S1). The sequence
identities are: mouse TC/human TC=73%; mouse TC/human
HC=28%; and mouse TC/human IF=28%. For comparison,
the sequence identity for human TC/human HC is 32% and for
human TC/human IF 26%.
Figure 3 shows a partial protein sequence alignment of the
previously predicted Cbl-binding-region of human HC, TC, and
IF [24] and the comparable region of mouse TC. The residues are
identical in human TC and mouse TC. Of importance to highlight
Figure 3. Partial protein sequence alignment of the predicted Cbi-binding region in human proteins. The alignment was done in
ClustalW2 using default settings. The region of the three human proteins has previously been predicted to be involved in binding to Cbl and the
highlighted residues are the ones expected to be responsible for the binding to Cbl (IF, TC, HC) and other corrinoids (HC only) [24]. For comparison,
the similar residue positions in mouse TC are highlighted as well. The numbers in the right margin refer to the specific amino acids of the full-length
protein including signal peptides. Complete protein sequence alignment is shown in Supporting Figure S1.
doi:10.1371/journal.pone.0020638.g003
Figure 4. Immunohistochemical localization of TC in mouse tissues using anti-mouse TC. (A, B) The submaxillary gland shows positive
staining in the granules of the granular, convoluted tubule cells. (C, D, E) Lactating mammary gland with some reaction in the luminal secretion.
Magnifications: (A, C) X 75, (B) X 300, (D, E) X 475.
doi:10.1371/journal.pone.0020638.g004
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ing histidine-residue in human TC is present in mouse TC (His74).
Taken together, the results from the sequence alignments
including DNA, mRNA and protein analysis all imply that the
mouse Cbl-binder is a TC.
Characterization of mouse Cbl-binding proteins by use of
specific antibodies
Polyclonal anti-mouse TC was produced in rabbit and proved
to recognize TC in the purified Cbl-binder from submaxillary
glands in a crude extract of submaxillary glands and in mouse
serum, see Figure 2B. The antibody did not show cross-reactivity
with equimolar amounts of human TC or HC (results not shown).
Anti-mouse TC was insolubilized on protein-A agarose. As
expected, the insoluble antibody was capable of precipitating the
Cbl-binding capacity and Cbl in extracts of mouse submaxillary
glands (.98% UB12BC and .93% Cbl precipitated) (data not
shown). Interestingly, the antibody also precipitated the Cbl-
binding capacity and Cbl in mice sera (.97% UB12BC and
.98% Cbl precipitated) (data not shown).
Immunohistochemical localisation of TC
The TC expression in mice was examined by immunohisto-
chemistry, Figure 4. TC was found in the granules of the granular,
convoluted tubule cells in the submaxillary glands and in the
luminal secretion in the lactating mammary glands.
Transcription level of mouse TC
We explored the transcription of TC in tissues known to
produce either TC or HC in humans.
The transcription level of TC in different tissues is depicted in
Figure 5 relative to their submaxillary gland transcription. A high
transcription level of mouse TC was seen in tissues known to have
high transcription levels of either TC or HC in humans [2],
notably the mammary, submaxillary, and parotid glands. The
small intestine, pancreas, and spleen showed low transcription
levels.
Discussion
We report that no HC-like protein is present in mice as
determined by BLAST analysis of the mouse genome. Instead,
the unsaturated Cbl-binding protein purified from mouse
submaxillary glands proved to be TC and not HC, as expected;
and serum contained TC as the only Cbl-binding protein.
Mouse TC shows features comparable to both human TC
(sequence, size, lack of ability to bind to Con-A) and human
HC (affinity towards Cbi, present at high levels in exocrine
glands).
Three soluble Cbl-binding proteins have been described.
Intrinsic factor is present in the gastrointestinal tract and
promotes the intestinal uptake of Cbl, while TC ensures
transport of Cbl in the blood stream and to all cells [25]. The
function of the third soluble transporter of Cbl, HC, remains to
be clarified. In humans, HC carries the major part of circulating
Cbl and it is present also in exocrine secretions like milk and
saliva [2]. While human IF and TC recognize only Cbl, HC is
able to recognize a wide spectrum of corrinoids including Cbi
[26]. IF, TC, and HC are structurally related and must have
emerged from a common ancestral gene. TC is considered to be
the oldest of the proteins with IF as the next in line. HC is likely
to have developed from a duplication of the IF gene and in
humans the genes coding for IF and HC both reside on
chromosome 11[27].
The occurrence in mammals of each of the circulating proteins
TC and HC has been documented by both direct and indirect
measures [4-9]. Notably TC has been purified from a number of
species including man, rabbit, cow, and now also from mice.
Likewise, HC has been purified from man, hog, and rabbit. Most
of these studies were based on indirect methods to classify the
nature of a given soluble Cbl-binding protein and, in doing so, a
Cbl-binding protein capable of binding Cbi has been classified as
a HC-type protein. Our results show that this is not enough to
prove protein identity. We demonstrate that mouse TC is able to
recognize Cbi; our results thereby warrant caution as to the
interpretation of previous data on the occurrence of HC in
mammals. Scrutiny of previous data on Cbl-binding proteins in
the rat reveals that the claimed presence of HC rests on evidence
that is somewhat indirect. The Cbl-binder in rat saliva was
classified as HC on the basis of its ability to bind Cbi, despite
other characteristics according to which the protein resembled
TC, e.g. a low carbohydrate content [8]. To explore a possible
existence of HC in rats at protein or genomic level (TCN1), we
performed a BLAST analysis; but as for the mouse, we identified
neither the protein nor the gene (data not shown). We thus find it
likely that neither the mouse nor the rat harbors a gene coding
for HC.
Our inability to find a gene coding for HC in the mouse genome
at the start of the present study made us believe that we would find
a new Cbl-binding protein to replace HC in mice. Instead, we
observed TC in all of the sites where HC was expected to occur.
Mouse TC-mRNA was transcribed at high levels in salivary and
mammary glands, whereas HC is located at these sites in humans.
Likewise, mouse TC was the only Cbl-binding protein present in
Figure 5. Comparison of the transcription levels of TC in
various mouse tissues. The transcription level of TC is shown for
each tissue (mean and SEM) relative to the transcription in submaxillary
glands (arbitrary value of 100). N=3 (submaxillary gland, kidney,
leucocytes, small intestine; 4 (mammary gland, parotid gland, pancreas,
spleen); 2 (liver).
doi:10.1371/journal.pone.0020638.g005
Mouse Transcobalamin
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contain HC in humans.
Together with previous reports, our data suggest that the nature
of the Cbl-binding protein in exocrine secretions may differ
amongst species. A known example is the difference between cow
and man who both have HC and TC. TC is the dominating Cbl-
binding protein in cow’s milk [28], while HC is found in human
milk. Our data show that TC may substitute HC, especially in
lower animals that may only have TC and not HC.
The binding of TC to other corrinoids besides Cbl is a novel
discovery. This ability has been related to HC in other mammals.
Wuerges et al. suggested that three residues in human HC are
responsible for its ability to bind Cbi: R
380,W
382, and Y
385; all
highlighted in Figure 3. In human IF and human TC, the position
of the HC residue R
380 is different (T
385 and S
374, respectively),
whereas residue W
382 in HC is also W in IF (W
376), but serine
(S
387) in TC. The position of Y
385 in human HC is also Y in
human TC (Y
390), but it is valine (V
379) in human IF. At these
three positions, mouse TC has residues identical to those of human
TC. These suggested residues are therefore not exclusively
responsible for the binding to Cbi, at least not in the mouse TC
protein. Point mutations in recombinant proteins and/or crystal-
lography of protein-Cbi complexes may show which residues are
truly involved in the binding of Cbl derivatives.
In conclusion, we report that in the mouse, TC is the only Cbl-
binding protein in serum and in tissues known to express HC.
Mouse TC behaves like an intermediate between human TC and
HC as it binds Cbi, but not Con-A.
Supporting Information
Figure S1 Complete sequence alignment depicting the
relation between various mammalian Cbl-binding
proteins. Protein sequence alignment of mouse TC, rat TC,
human TC, human IF, and human HC. The residues highlighted
with yellow show the Cobalt-coordinating histidine-residues in
mouse TC, rat, TC, and human TC. The residues highlighted
with red are expected to be responsible for the binding to Cbl (IF,
TC, HC) and other corrinoids (HC only) [24]. The numbers in the
right margin refer to the specific amino acids of the full-length
protein including signal peptides.
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